Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Case Series on the Effects of Xolair (Omalizumab) in Bullous Pemphigoid

NCT00472030 is registered in ClinicalTrials.gov with University of Iowa as lead sponsor.

NCT NCT00472030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00472030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Case Series on the Effects of Xolair (Omalizumab) in Bullous Pemphigoid
Lead sponsor
University of Iowa
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2007
Completion date
December 31, 2010
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bullous pemphigoid